Access Resources
326 - 350 of 7540 Results
Title
Year
-
RESTRICTEDTitle: Leucine-rich repeat kinase 2 at a glanceJournal Name: Journal of Cell SciencePublisher: The Company of BiologistsVol: 136Issue #: 17Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1242/jcs.259724Best OA location URL: https://journals.biologists.com/jcs/article-pdf/136/17/jcs259724/3144584/jcs259724.pdfCitation Count: 3
- No laughing white matter: Reduced integrity of the cortical cholinergic pathways in Parkinson's disease-related cognitive impairment2023RESTRICTEDTitle: No laughing white matter: Reduced integrity of the cortical cholinergic pathways in Parkinson's disease-related cognitive impairmentJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 185Issue #:Start Page: 106243End Page: 106243Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2023.106243Best OA location URL: https://doi.org/10.1016/j.nbd.2023.106243Citation Count: 2
- Novel human pluripotent stem cell-derived hypothalamus organoids demonstrate cellular diversity2023RESTRICTEDTitle: Novel human pluripotent stem cell-derived hypothalamus organoids demonstrate cellular diversityJournal Name: iSciencePublisher: Elsevier BVVol: 26Issue #: 9Start Page: 107525End Page: 107525Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.isci.2023.107525Best OA location URL: http://www.cell.com/article/S2589004223016024/pdfCitation Count: 2
- Patients’ Preferences for Adjunctive Parkinson’s Disease Treatments: A Discrete-Choice Experiment2023RESTRICTEDTitle: Patients’ Preferences for Adjunctive Parkinson’s Disease Treatments: A Discrete-Choice ExperimentJournal Name: Patient Preference and AdherencePublisher: Informa UK LimitedVol: Volume 17Issue #:Start Page: 2263End Page: 2277Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.2147/ppa.s420051Best OA location URL: https://www.dovepress.com/getfile.php?fileID=92760Citation Count: 0
- Prediction of Parkinson’s disease pathogenic variants using hybrid Machine learning systems and radiomic features2023RESTRICTEDTitle: Prediction of Parkinson’s disease pathogenic variants using hybrid Machine learning systems and radiomic featuresJournal Name: Physica MedicaPublisher: Elsevier BVVol: 113Issue #:Start Page: 102647End Page: 102647Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ejmp.2023.102647Citation Count: 0
- Prevalence and Clinical Implications of a β-Amyloid–Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer Disease2023RESTRICTEDTitle: Prevalence and Clinical Implications of a β-Amyloid–Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 80Issue #: 9Start Page: 969End Page: 969Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1001/jamaneurol.2023.2338Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2807607/jamaneurology_erickson_2023_oi_230049_1689611082.26721.pdfCitation Count: 4
- Safety, tolerability, and preliminary efficacy of SYN120, a dual 5-HT6/5-HT2A antagonist, for the treatment of Parkinson disease dementia: A randomized, controlled, proof-of-concept trial2023RESTRICTEDTitle: Safety, tolerability, and preliminary efficacy of SYN120, a dual 5-HT6/5-HT2A antagonist, for the treatment of Parkinson disease dementia: A randomized, controlled, proof-of-concept trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 114Issue #:Start Page: 105511End Page: 105511Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105511Citation Count: 1
- Spatially heterogeneous structure-function coupling in haemodynamic and electromagnetic brain networks2023RESTRICTEDTitle: Spatially heterogeneous structure-function coupling in haemodynamic and electromagnetic brain networksJournal Name: NeuroImagePublisher: Elsevier BVVol: 278Issue #:Start Page: 120276End Page: 120276Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuroimage.2023.120276Best OA location URL: https://doi.org/10.1016/j.neuroimage.2023.120276Citation Count: 2
-
RESTRICTEDTitle: Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00573-2Best OA location URL: https://www.nature.com/articles/s41531-023-00573-2.pdfCitation Count: 1
-
RESTRICTEDTitle: NeuroBridge: a prototype platform for discovery of the long-tail neuroimaging dataJournal Name: Frontiers in NeuroinformaticsPublisher: Frontiers Media SAVol: 17Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fninf.2023.1215261Best OA location URL: https://www.frontiersin.org/articles/10.3389/fninf.2023.1215261/pdfCitation Count: 0
-
RESTRICTEDTitle: A blood-based marker of mitochondrial DNA damage in Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 15Issue #: 711Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.abo1557Citation Count: 9
- Changes in α-Synuclein Posttranslational Modifications in an AAV-Based Mouse Model of Parkinson’s Disease2023RESTRICTEDTitle: Changes in α-Synuclein Posttranslational Modifications in an AAV-Based Mouse Model of Parkinson’s DiseaseJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 24Issue #: 17Start Page: 13435End Page: 13435Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms241713435Best OA location URL: https://www.mdpi.com/1422-0067/24/17/13435/pdf?version=1693464631Citation Count: 2
- Multiancestry analysis of the HLA locus in Alzheimer’s and Parkinson’s diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes2023RESTRICTEDTitle: Multiancestry analysis of the HLA locus in Alzheimer’s and Parkinson’s diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypesJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 120Issue #: 36Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1073/pnas.2302720120Best OA location URL: https://doi.org/10.1073/pnas.2302720120Citation Count: 3
- A Fixable Fluorescence‐Quenched Substrate for Quantitation of Lysosomal Glucocerebrosidase Activity in Both Live and Fixed Cells2023RESTRICTEDTitle: A Fixable Fluorescence‐Quenched Substrate for Quantitation of Lysosomal Glucocerebrosidase Activity in Both Live and Fixed CellsJournal Name: Angewandte Chemie International EditionPublisher: WileyVol: 62Issue #: 40Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/anie.202309306Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/anie.202309306Citation Count: 0
- A Fixable Fluorescence‐Quenched Substrate for Quantitation of Lysosomal Glucocerebrosidase Activity in Both Live and Fixed Cells2023RESTRICTEDTitle: A Fixable Fluorescence‐Quenched Substrate for Quantitation of Lysosomal Glucocerebrosidase Activity in Both Live and Fixed CellsJournal Name: Angewandte ChemiePublisher: WileyVol: 135Issue #: 40Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ange.202309306Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ange.202309306Citation Count: 0
- Insight into the Binding of First- and Second-Generation PET Tracers to 4R and 3R/4R Tau Protofibrils2023RESTRICTEDTitle: Insight into the Binding of First- and Second-Generation PET Tracers to 4R and 3R/4R Tau ProtofibrilsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 14Issue #: 18Start Page: 3528End Page: 3539Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.3c00437Best OA location URL: https://doi.org/10.1021/acschemneuro.3c00437Citation Count: 4
- Frequency and phenotypic spectrum of spinocerebellar ataxia 27B and other genetic ataxias in a Spanish cohort of late‐onset cerebellar ataxia2023RESTRICTEDTitle: Frequency and phenotypic spectrum of spinocerebellar ataxia 27B and other genetic ataxias in a Spanish cohort of late‐onset cerebellar ataxiaJournal Name: European Journal of NeurologyPublisher: WileyVol: 30Issue #: 12Start Page: 3828End Page: 3833Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ene.16039Citation Count: 6
- Associations of Apolipoprotein ε4 Genotypes with Motor and Nonmotor Symptoms in Parkinson's Disease: A Cross‐Sectional Study2023RESTRICTEDTitle: Associations of Apolipoprotein ε4 Genotypes with Motor and Nonmotor Symptoms in Parkinson's Disease: A Cross‐Sectional StudyJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 11Start Page: 1611End Page: 1619Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13862Best OA location URL: https://doi.org/10.1002/mdc3.13862Citation Count: 0
- The Avidity of Autoreactive Alpha-Synuclein Antibodies in Leucine-Rich Repeat Kinase 2 Mutation Carriers Is Not Altered Compared to Healthy Controls or Patients with Parkinson’s Disease2023RESTRICTEDTitle: The Avidity of Autoreactive Alpha-Synuclein Antibodies in Leucine-Rich Repeat Kinase 2 Mutation Carriers Is Not Altered Compared to Healthy Controls or Patients with Parkinson’s DiseaseJournal Name: BiomoleculesPublisher: MDPI AGVol: 13Issue #: 9Start Page: 1303End Page: 1303Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom13091303Best OA location URL: https://www.mdpi.com/2218-273X/13/9/1303/pdf?version=1692936929Citation Count: 0
-
RESTRICTEDTitle: Lifespan neurodegeneration of the human brain in multiple sclerosisJournal Name: Human Brain MappingPublisher: WileyVol: 44Issue #: 17Start Page: 5602End Page: 5611Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/hbm.26464Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hbm.26464Citation Count: 3
- Reference LINE-1 insertion polymorphisms correlate with Parkinson’s disease progression and differential transcript expression in the PPMI cohort2023RESTRICTEDTitle: Reference LINE-1 insertion polymorphisms correlate with Parkinson’s disease progression and differential transcript expression in the PPMI cohortJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-023-41052-1Best OA location URL: https://www.nature.com/articles/s41598-023-41052-1.pdfCitation Count: 1
-
RESTRICTEDTitle: Network Connectivity Alterations across the MAPT Mutation Clinical SpectrumJournal Name: Annals of NeurologyPublisher: WileyVol: 94Issue #: 4Start Page: 632End Page: 646Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/ana.26738Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.26738Citation Count: 0
- Spinal cord and brain concentrations of riluzole after oral and intrathecal administration: A potential new treatment route for amyotrophic lateral sclerosis2023RESTRICTEDTitle: Spinal cord and brain concentrations of riluzole after oral and intrathecal administration: A potential new treatment route for amyotrophic lateral sclerosisJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 18Issue #: 8Start Page: e0277718End Page: e0277718Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0277718Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0277718&type=printableCitation Count: 0
-
RESTRICTEDTitle: Transdermal Nicotine Treatment and Progression of Early Parkinson’s DiseaseJournal Name: NEJM EvidencePublisher: Massachusetts Medical SocietyVol: 2Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1056/evidoa2200311Citation Count: 2
- Neurofilament light chain in spinal fluid and plasma in multiple system atrophy: a prospective, longitudinal biomarker study2023RESTRICTEDTitle: Neurofilament light chain in spinal fluid and plasma in multiple system atrophy: a prospective, longitudinal biomarker studyJournal Name: Clinical Autonomic ResearchPublisher: Springer Science and Business Media LLCVol: 33Issue #: 6Start Page: 635End Page: 645Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s10286-023-00974-6Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418538Citation Count: 1